A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects

Courtney De Vries, Svetla Gadzhanova, Matthew J. Sykes, Michael Ward, Elizabeth Roughead
doi: https://doi.org/10.1101/2020.02.24.20027532

Article usage

Article usage: February 2020 to November 2024

AbstractFullPdf
Feb 202092015
Mar 2020128049
Apr 202080032
May 2020131033
Jun 202083025
Jul 202045014
Aug 202080025
Sep 202087039
Oct 202081038
Nov 202055140
Dec 202041936
Jan 202155829
Feb 2021771132
Mar 2021941744
Apr 2021791023
May 2021561817
Jun 2021521929
Jul 2021281316
Aug 2021342220
Sep 202135829
Oct 2021261635
Nov 2021331030
Dec 2021241113
Jan 2022281523
Feb 2022291222
Mar 202233917
Apr 202222020
May 202229913
Jun 20221745
Jul 202224813
Aug 20221899
Sep 202231713
Oct 2022311915
Nov 202213059
Dec 20223886
Jan 202320813
Feb 202319121
Mar 202314278
Apr 202325199
May 2023111411
Jun 202311244
Jul 20235335
Aug 202319438
Sep 202318403
Oct 202310341
Nov 202312418
Dec 202314286
Jan 20244377
Feb 202422467
Mar 2024123415
Apr 202418379
May 202425308
Jun 2024343712
Jul 2024161726
Aug 2024262320
Sep 2024212515
Oct 2024192416
Nov 2024101
Back to top
Posted February 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email
A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects
Courtney De Vries, Svetla Gadzhanova, Matthew J. Sykes, Michael Ward, Elizabeth Roughead
medRxiv 2020.02.24.20027532; doi: https://doi.org/10.1101/2020.02.24.20027532
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area